Log In
Print
BCIQ
Print
Print this Print this
 

Ultresa, pancrelipase

  Manage Alerts
Collapse Summary General Information
Company Actavis plc
DescriptionDelayed-release pancrelipase formulation
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationPancreatic insufficiency
Indication DetailsTreat exocrine pancreatic insufficiency due to cystic fibrosis (CF)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today